Trial record 1 of 1 for:
DARPIN | AML/MDS
Study of MP0533 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05673057 |
|
Recruitment Status :
Recruiting
First Posted : January 6, 2023
Last Update Posted : January 24, 2024
|
Sponsor:
Molecular Partners AG
Information provided by (Responsible Party):
Molecular Partners AG
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | December 2025 |
| Estimated Study Completion Date : | December 2027 |